1 completed, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Barcelona Macula Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Structural and Functional Characterization of Rare Ocular Diseases Retinitis Pigmentosa, Stargardt Disease 1 | Unknown | Barcelona Macula Foundation | 50 | 2021-11-24 | 2022-03-15 | |
| Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor 0.5mg aflibercept - Wet Macular Degeneration | Phase 4 | Completed | Barcelona Macula Foundation | 46 | 2013-07-01 | 2018-11-23 |
Choroideremia (1) · Retinitis Pigmentosa (1) · Stargardt Disease (1) · Vitelliform Macular Dystrophy (1) · Wet Macular Degeneration (1)
aflibercept (1)
Spain (2)
Carlos Juan Donate, MD (1) · Francisco Cabrera, MD (1) · Javier Araiz, MD (1) · Jordi Mones, MD PhD (1) · Jose Luis Olea, MD (1) · Jose Maria Ruiz-Moreno, MD (1) · Laura Sarasols, MD (1)